Ozempic 0.25 mg is a GLP-1 receptor agonist used in the treatment of type 2 diabetes. It helps regulate blood sugar levels and improves insulin sensitivity. Administered as a once-weekly subcutaneous injection, it is recommended to be used alongside diet and exercise. The 0.25 mg dose is typically the starting dose to help the body adjust, with plans to increase to a higher maintenance dose if needed.
Ozempic 0.25 mg is an effective starting dose of a GLP-1 receptor agonist designed for adults with type 2 diabetes. It works by enhancing insulin secretion, reducing glucagon levels, and slowing gastric emptying, which helps regulate blood sugar levels throughout the day. Administered once weekly as a subcutaneous injection, it is intended to be used alongside a balanced diet and regular exercise for optimal results. This initial dose allows the body to adjust to the medication and minimizes potential side effects before moving to a higher maintenance dose.